To assess the effects of WP1066 on tumour cell apoptosis, sections from the WP1066 or DMSO-treated cohorts were stained with an antibody against cleaved caspase 3, a marker of apoptotic cell death (Fig. 3H, I). Here, CASP3 is linked to neoplasm.